Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression.

Saved in:
Bibliographic Details
Title: Tumor Expression of CD83 Reduces Glioma Progression and Is Associated with Reduced Immunosuppression.
Authors: McDonald MF; Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas.; Development, Disease Models, and Therapeutics, Baylor College of Medicine, Houston, Texas.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Curry RN; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., O'Reilly I; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Lozzi B; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Cervantes A; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Lee ZF; Development, Disease Models, and Therapeutics, Baylor College of Medicine, Houston, Texas.; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Rosenbaum A; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., He P; Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas., Mohila C; Department of Pathology, Texas Children's Hospital, Houston, Texas., Harmanci AO; School of Biomedical Informatics, University of Texas Health Science Center, Houston, Texas., Serin Harmanci A; Center for Cancer Neuroscience, Baylor College of Medicine, Houston, Texas.; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Deneen B; Development, Disease Models, and Therapeutics, Baylor College of Medicine, Houston, Texas.; Center for Cancer Neuroscience, Baylor College of Medicine, Houston, Texas.; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas., Rao G; Center for Cancer Neuroscience, Baylor College of Medicine, Houston, Texas.; Department of Neurosurgery, Baylor College of Medicine, Houston, Texas.
Source: Cancer research communications [Cancer Res Commun] 2024 Dec 01; Vol. 4 (12), pp. 3209-3223.
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9918281580506676 Publication Model: Print Cited Medium: Internet ISSN: 2767-9764 (Electronic) Linking ISSN: 27679764 NLM ISO Abbreviation: Cancer Res Commun Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2767-9764
DOI:10.1158/2767-9764.CRC-24-0281